All Reports Events Blogs Videos
Showing 5 results
  • R&D Strategic Technology Outlook
    Aug. 27, 2026

    The biomanufacturing landscape is shifting from fixed process settings, periodic sampling, and end-point testing toward real-time, data-driven process control. The growing complexity of biologics, cell and gene therapies, mRNA therapeutics, and antibody-drug conjugates is increasing the…
  • Viewpoint
    Sep. 30, 2025

    Investment banking enterprises face mounting pressure from volatile macroeconomic conditions, fee compression, disintermediation through special purpose acquisition companies and direct listings, and increasingly complex regulatory mandates such as Basel III/IV, MiFID II, and Dodd-Frank. Traditional human-led…